Latest News about NMDBF
Recent news which mentions NMDBF
World Class Leaders In Psychedelics Form Benzinga's Psychedelic Advisory Council—Get To Know Them
August 30, 2022
From Benzinga
From Benzinga
NeonMind To Improve Patient Care And Data Management With Thrive Health's Digital Healthcare Platform
April 22, 2022
From Benzinga
Psyched: Third Michigan City Decriminalizes Psychedelics, MindMed Reports $133M Cash Position, Real Brands To Enter The Space
March 29, 2022
From Benzinga
Psyched: Albert Labs Goes Public, Ex-Moderna Executive Joins MAPS, Novamind and Usona Join For Phase 2 Psilocybin Trial
March 15, 2022
From Benzinga
NeonMind Completes Pre-IND Consultation With FDA And Strengthens Medical Services Division
March 10, 2022
Tickers
NMDBF
From Benzinga
Psyched: First Australian Psych Company On Nasdaq, Utah's Psychedelics Bill, LSD Vs. Psilocybin Study Unprecedented Results
March 07, 2022
From Benzinga
NeonMind Teams Up With BioScript Solutions To Expand Its Clinic Network For Interventional Psychiatry Treatments
March 03, 2022
Tickers
NMDBF
From Benzinga
From Benzinga
NeonMind Appoints Dr. Dinesh Bhayana As Site Medical Director Of Its First Mental Health Clinic
February 24, 2022
Tickers
NMDBF
From Benzinga
NeonMind To Open Its First Specialty Mental Health Clinic In Ontario, More To Come
February 17, 2022
Tickers
NMDBF
From Benzinga
Benzinga's Unprecedented Psychedelics Investing Conference Lands In Miami On April 19th
February 09, 2022
From Benzinga
Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation
October 18, 2021
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.